Traumatic Brain Injuries Assessment Market Research, 2031
The global traumatic brain injuries assessment market size was valued at $9.6 billion in 2021, and is projected to reach $18.4 billion by 2031, growing at a CAGR of 7% from 2022 to 2031. Taumatic Brain Injury (TBI) is a disruption in the normal operation of the brain caused by a blow, bump, or shock to the head, the head striking an item quickly and violently, or when an object pierces the skull and penetrates brain tissue. TBI symptoms can be minor, moderate, or severe, depending on the extent of brain injury. Mild cases may cause a temporary shift in mental state or consciousness. Severe cases may result in prolonged unconsciousness, coma, or even death.
The global traumatic brain injuries assessment market trend is expanding across all segments and geographical areas due to the growing population and rising per capita incomes, which have changed consumer demand for highly sophisticated and technologically advanced products and equipment. Moreover, the increase in health awareness campaigns and programs that motivate people to take better care of their health and be more aware of the diseases that can be brought on by using certain products is a significant factor that drives the global market for the treatment of traumatic brain injuries.
The high cost of treating traumatic brain injuries is a significant barrier. The market share of traumatic brain injuries treatments also decreases due to the inability to treat a wide variety of patients from different sociological sectors, which stops the majority of patients who lack sufficient financial resources from seeking treatment.
This report provides an overview of the global traumatic brain injuries assessment market opportunity, the largest markets, and key players, as well as their current and future developments. The study's goals are to present of the traumatic brain injuries assessment market growth in China, Europe, and the U.S. Favorable government policies and initiatives, as well as the increase in patient preference for minimally invasive brain or other related surgeries, are expected to have a significant impact on the revenue growth of the global traumatic brain injuries assessment market in the coming years. These advantages include a lower risk of infection, high efficacy, quick recovery times, and minimal pain inflicted.
The global traumatic brain injuries assessment market forecast is segmented into end-user, diagnostic type, and region. On the basis of end-user, the market is segmented into hospital, diagnostics center, and others. On the basis of diagnostic type, the market is classified into CT-scan, MRI, intracranial pressure monitoring, partial pressure of oxygen in brain tissue (pBrO2), and others. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players profiled in this report include Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.
The traumatic brain injuries assessment market is segmented into End-user and Diagnostic Type.
On the basis of end-user, the hospital -segment dominated the traumatic brain Injuries assessment market share in 2021. The hospital segment led the market because brain surgeries are among the most challenging procedures and require specialized equipment that is only available in hospitals. This is a major factor that is expected to affect the traumatic brain injuries assessment market size during the forecast period.
On the basis of diagnostic type, the CT-scan segment dominated the global traumatic brain injuries assessment market share in 2021. A CT scan can quickly visualize fractures and uncover evidence of bleeding in the brain (hemorrhage), blood clots (hematomas), bruised brain tissue (contusions), and brain tissue swelling. The application of CT-scan for traumatic brain injuries assessment has scope for growth during the forecast period.
On the basis of region, North America dominated the global traumatic brain injuries assessment analysis market in 2021 and is projected to remain the fastest-growing region during the forecast period. The traumatic brain injuries assessment market in North America is divided into the U.S., Canada, and Mexico on the basis of country. The U.S. had the highest market share for traumatic brain injuries assessment in North America in 2021. However, the market in North America suffered greatly as a result of the COVID-19 pandemic. Low production and a shaky supply chain are problems in the manufacturing sectors of North American nations.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the traumatic brain injuries assessment market analysis from 2021 to 2031 to identify the prevailing traumatic brain injuries assessment market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the traumatic brain injuries assessment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global traumatic brain injuries assessment market trends, key players, market segments, application areas, and market growth strategies.
Impact of COVID-19 on the Global Traumatic Brain Injuries Assessment Market
- The Covid-19 pandemic’s impact has prompted several traumatic brain injuries therapy companies to lay off employees, but it is anticipated that the market will soon pick up the pace and demand will rise. It is projected that the post-lockdown phase will be very beneficial for the market.
- Traumatic brain injuries TBIs happened early in the pandemic at rates similar to those from previous years. The number of patients with TBIs decreased during the first eight weeks of the pandemic, but this was rapidly followed by an obvious increase during the next eight, and eventually the rates of TBIs were equivalent between the pre-COVID-19 and COVID-19 periods.
- The COVID-19 pandemic also increased the demand for TBI evaluation and management technologies in 2020. Several patients who were treated for coronavirus infection showed clinical and neurochemical signs of brain injury, according to a study that was published in the NCBI report 2020.
- The COVID-19 pandemic has had a tremendous impact on the scientific study of traumatic brain injury. The TBI field had a "lost year" as experimental and clinical research either slowed down or was discontinued, and funding was redistributed. Despite this, the pandemic marked a turning point. This report discusses the philosophical and technological lessons that may be learned from the COVID-19 pandemic to increase the classification, diagnostic, and therapeutic efficacy of TBI.
Traumatic brain injuries assessment Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 18.4 billion |
 Growth Rate | CAGR of 7% |
 Forecast period | 2021 - 2031 |
 Report Pages | 250 |
 By End-user |
|
 By Diagnostic Type |
|
 By Region |
|
 Key Market Players | RAUMEDIC AG, Nihon Kohden Corp., Natus Medical Incorporated, BioDirection, Inc., brainscope company inc., Compumedics Ltd., NOVASIGNAL CORPORATION, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, Koninklijke Philips N.V. |
Analyst Review
Growing rate of traumatic brain injuries and technological improvements are a couple of reasons boosting the market's expansion. The increase in demand for non-invasive technologies and the rise in sports injuries and auto accidents will both provide tremendous growth prospects. The usage of pressure monitors is another significant trend that is boosting the market share growth of traumatic brain injury diagnostic and management equipment. The expansion of market participants; however, is hampered by the treatment's ambiguous timing, which is a loss relating to a family member's physical absence but psychological presence or a loss relating to a family member's psychological absence but physical presence, and duration. Market vendors should try to retain their positions in the segments that are growing slowly while concentrating more on their growth prospects in the ones that are expanding quickly. The increase in traumatic brain injuries, basic disorders, intensive R&D and rise in clinical studies are further anticipated to be major factors boosting the growth of the market.
Among the analyzed regions, North America is expected to account for the highest revenue in the market by the end of 2031, followed by Asia-Pacific and Europe. LAMEA is experiencing an increase in the number of accidents involving brain contusions and penetrating brain injury occurrences, as well as intensive R&D by FDA scientists across regions. This will augment the global traumatic brain injuries assessment market.
The development of medication therapies is the main driver that propels the global market for therapeutics for traumatic brain injury. The market's expansion is constrained by delayed diagnoses and insufficient government financing for TBI treatment research. Hence, there are enormous development prospects as the demand for non-invasive technologies grows, cases of sports injuries rise, and TBI awareness increases.
North America will provide more business opportunities for the global traumatic brain injuries assessment market in the future.
The global traumatic brain injuries assessment market size was valued at $9,570 million in 2021 and is projected to reach $18,373.6 million by 2031, expanding at an expected CAGR of 7.0% from 2022 to 2031.
Integra Life Sciences, Bio Direction, Inc., and Nihon Kohden Corp. are the major players in the traumatic brain injuries assessment market.
The major growth strategies adopted by traumatic brain injuries assessment market players are product launches and mergers & acquisitions.
Loading Table Of Content...
